NO20004523L - Avleveringssystem for Õ modulere immunrespons - Google Patents

Avleveringssystem for Õ modulere immunrespons

Info

Publication number
NO20004523L
NO20004523L NO20004523A NO20004523A NO20004523L NO 20004523 L NO20004523 L NO 20004523L NO 20004523 A NO20004523 A NO 20004523A NO 20004523 A NO20004523 A NO 20004523A NO 20004523 L NO20004523 L NO 20004523L
Authority
NO
Norway
Prior art keywords
immune response
delivery system
modulating immune
modulating
delivery
Prior art date
Application number
NO20004523A
Other languages
English (en)
Other versions
NO20004523D0 (no
Inventor
Roberto L Rivera
Original Assignee
Allergenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergenics Inc filed Critical Allergenics Inc
Publication of NO20004523D0 publication Critical patent/NO20004523D0/no
Publication of NO20004523L publication Critical patent/NO20004523L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20004523A 1998-03-12 2000-09-11 Avleveringssystem for Õ modulere immunrespons NO20004523L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/041,514 US6328967B1 (en) 1998-03-12 1998-03-12 Delivery system to modulate immune response
PCT/US1999/005128 WO1999045904A1 (en) 1998-03-12 1999-03-09 Delivery system to modulate immune response

Publications (2)

Publication Number Publication Date
NO20004523D0 NO20004523D0 (no) 2000-09-11
NO20004523L true NO20004523L (no) 2000-11-03

Family

ID=21916921

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004523A NO20004523L (no) 1998-03-12 2000-09-11 Avleveringssystem for Õ modulere immunrespons

Country Status (10)

Country Link
US (2) US6328967B1 (no)
EP (1) EP1061903A1 (no)
JP (1) JP2002506019A (no)
CN (1) CN1292686A (no)
AU (1) AU748882B2 (no)
CA (1) CA2322472A1 (no)
NO (1) NO20004523L (no)
NZ (1) NZ506479A (no)
PL (1) PL342936A1 (no)
WO (1) WO1999045904A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
CA2322641C (en) 1998-03-23 2010-02-16 General Mills, Inc. Encapsulation of components into edible products
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions
KR20020021397A (ko) 1999-07-22 2002-03-20 데이비드 엠 모이어 규정된 에피토프 영역에 아미노산 결실 및 치환을 갖는서브틸리신 프로테아제 변이체
AU6085800A (en) 1999-07-22 2001-02-13 Procter & Gamble Company, The Subtilisin protease variants having amino acid substitutions in defined epitope regions
MXPA02000842A (es) 1999-07-22 2002-07-30 Procter & Gamble Conjugados de proteasa que tienen sitios de corte protegidos estericamente.
EP1244468A2 (en) * 2000-01-07 2002-10-02 University Of Cincinnati Selective activation of a th1 or th2 lymphocyte regulated immune response
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
WO2002032403A1 (fr) * 2000-10-16 2002-04-25 Daiichi Pharmaceutical Co., Ltd. Compositions medicales pouvant se desintegrer rapidement dans la cavite buccale et leur procede de production
EP1372713A4 (en) * 2001-04-02 2010-01-13 Genencor Int GRANULATE WITH REDUCED DUST POTENTIAL
US8076113B2 (en) * 2001-04-02 2011-12-13 Danisco Us Inc. Method for producing granules with reduced dust potential comprising an antifoam agent
WO2003043574A2 (en) 2001-11-19 2003-05-30 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
US20040043070A1 (en) * 2002-05-14 2004-03-04 Ayres James W. Hot melt coating by direct blending and coated substrates
KR100530369B1 (ko) * 2002-05-27 2005-11-22 이영환 항암물질에 나노입자를 결합시킨 주사 제형의 약물 시스템
US7431986B2 (en) 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
US20070141071A1 (en) * 2003-05-14 2007-06-21 Oregon State University Hot melt coating by direct blending and coated substrates
WO2005123239A1 (en) * 2004-06-18 2005-12-29 Unilever Plc Method of growing crystals
ES2341968T3 (es) * 2004-06-18 2010-06-30 Unilever N.V. Procedimiento de crecimiento de cristales.
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
WO2007112747A1 (en) * 2006-03-31 2007-10-11 Curalogic A/S Immunogen combinations
EP2197421A1 (en) * 2007-08-31 2010-06-23 Amgen, Inc Solid-state protein formulation
CH701350A1 (it) * 2009-06-24 2010-12-31 Artcell Invest Ltd Metodo per il trattamento dell'arterosclerosi.
WO2011079282A1 (en) * 2009-12-23 2011-06-30 Vaxgene Corporation Immunoprotection by oral administration of recombinant lactococcus lactis mini-capsules
ES2644138T3 (es) 2011-06-13 2017-11-27 Rival S.E.C N,N,N-trialquilpolímeros, métodos para su preparación y usos de los mismos
JP6912394B2 (ja) 2015-06-12 2021-08-04 バクサート インコーポレイテッド Ｒｓｖおよびノロウイルス抗原の小腸送達のための製剤
KR20230169127A (ko) * 2021-04-13 2023-12-15 일루미나 케임브리지 리미티드 캡슐화된 동결건조 미소구체를 제조 및 사용하는 조성물, 시스템, 및 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1037792A (en) * 1964-03-13 1966-08-03 Konditerskaja Fabrika Im Marat Enteric coated oral vaccines for intestinal infections
US5417986A (en) * 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
JPH07116057B2 (ja) 1988-05-11 1995-12-13 理化学研究所 免疫増強剤及び強化抗原
JPH06508371A (ja) * 1991-06-21 1994-09-22 ユニバーシティー オブ シンシナティ 経口投与できる治療用タンパク質及びその製法
DE69305313T3 (de) 1992-12-22 2001-06-21 The University Of Cincinnati, Cincinnati Orale Verabreichung von immunologischen aktiven Biomolekülen und anderen therapeutischen Proteinen
NZ265818A (en) 1993-04-19 1997-09-22 Medisorb Technologies Internat Compositions of nucleic acids encapsulated with molecules that facilitate uptake and integration into living cells
FR2723849B1 (fr) 1994-08-31 1997-04-11 Biovector Therapeutics Sa Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique

Also Published As

Publication number Publication date
CN1292686A (zh) 2001-04-25
EP1061903A1 (en) 2000-12-27
NO20004523D0 (no) 2000-09-11
AU748882B2 (en) 2002-06-13
AU2993099A (en) 1999-09-27
NZ506479A (en) 2004-12-24
WO1999045904A1 (en) 1999-09-16
JP2002506019A (ja) 2002-02-26
US6328967B1 (en) 2001-12-11
US20020034514A1 (en) 2002-03-21
PL342936A1 (en) 2001-07-16
CA2322472A1 (en) 1999-09-16

Similar Documents

Publication Publication Date Title
NO20004523L (no) Avleveringssystem for Õ modulere immunrespons
DE69711045D1 (de) Vitamin c abgabesystem
NO972093D0 (no) Pumpesystem
DE19882536T1 (de) Doppelpumpenanlage
DE69822529D1 (de) Stentanbringungssystem
NL1003571A1 (nl) Pompstelsel.
DE69821928D1 (de) Intrakardiales defibrillierungssystem
ID21702A (id) Sistim dispenser
DE69832055D1 (de) Transdermales abgabesystem
DE69816858D1 (de) Beatmungssystem
DE69836715D1 (de) Nachrichtenübertragungssystem
ID26105A (id) Sistem transaksi
DE69833445D1 (de) Verbindersystem
DE69801983D1 (de) Verbindungssystem
ID23428A (id) Stabilisator uv untuk sistem siloksan
DE69915677D1 (de) Vordrucksystem
DE69734043D1 (de) Parfümfreisetzungssystem
DE59811803D1 (de) Kommunikationssystem
NO20016377D0 (no) Forbedret strömningsfordelingssystem
DE19782185T1 (de) Pumpensystem
DE59802576D1 (de) Schienenfahrzeugsystem
DE69818391D1 (de) Nebenabflusssystem
FI974143A7 (fi) Liitäntäjärjestelmä lämmityslaitteita varten
DE69811604D1 (de) Förderanlage
DE59802979D1 (de) Kommunikationssystem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application